Literature DB >> 30697298

Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-Center Experience.

Abhimanyu Sharma1, Meera Sikka1, Sunil Gomber2, Satendra Sharma1.   

Abstract

BACKGROUND &
OBJECTIVE: In sepsis, enhanced fibrin formation, impaired fibrin degradation, and intravascular fibrin deposition lead to a prothrombotic state. The current study aimed at measuring various coagulation parameters to predict an early marker for disseminated intravascular coagulation(DIC).
METHODS: The current prospective study was conducted from January 2012 to April 2013 on 50 children aged 1-10 years with clinically suspected sepsis referred to the Department of Pediatrics of a tertiary care center in New Delhi, India. Patients were evaluated in accordance with criteria for acute infection (ie, symptoms less than seven days) confirmed in all patients in the laboratory. Patients receiving antibiotics 24-48 hours preceding admission were excluded from the study. Prothrombin time, activated partial thromboplastin time, plasma fibrinogen, and D-dimer were measured at the time of admission in 50 patients and 50 controls. RESULTS &
CONCLUSION: D-dimer was positive in 36 (72%) patients and negative in all controls. The difference was statistically significant (P<0.01). Plasma fibrinogen was significantly (P<0.01) higher in patients compared with the controls. It was decreased in 6% and increased in 8% of the patients, and normal in all controls.PT and APTT were significantly (P<0.01) higher in patients compared with the controls.Though none of the current study patients developed overt disseminated intravascular coagulation, the high positivity for D-dimer suggested that it should be measured in children with sepsis for early identification of DIC. This can aid better management as additional coagulation based therapy such as recombinant anti-thrombin and thrombomodulin may help to improve prognosis.

Entities:  

Keywords:  Child; Disseminated Intravascular Coagulation (DIC); India; Sepsis

Year:  2018        PMID: 30697298      PMCID: PMC6339482     

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


  15 in total

1.  Global fibrinolytic capacity in neonatal sepsis.

Authors:  Erdal Peker; Sinan Akbayram; Hadi Geylani; Murat Dogan; Ercan Kirimi
Journal:  Clin Appl Thromb Hemost       Date:  2010-11-15       Impact factor: 2.389

Review 2.  Sepsis, thrombosis and organ dysfunction.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Thromb Res       Date:  2011-11-05       Impact factor: 3.944

3.  [Investigation of hemostatic changes in patients with sepsis].

Authors:  Gee-Young Kim; Su-Yon Park; Hwi-Joong Yoon; Jin-Tae Suh; So-Young Kang; Woo-In Lee
Journal:  Korean J Lab Med       Date:  2007-06

4.  Prognostic value of initial antithrombin levels in neonatal sepsis.

Authors:  Betul Ersoy; Hakan Nehir; Serdar Altinoz; Ozge Yilmaz; Pinar Erbay Dundar; Aysel Aydogan
Journal:  Indian Pediatr       Date:  2007-08       Impact factor: 1.411

Review 5.  The host response to sepsis and developmental impact.

Authors:  James Wynn; Timothy T Cornell; Hector R Wong; Thomas P Shanley; Derek S Wheeler
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

6.  Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.

Authors:  A C Mavrommatis; T Theodoridis; M Economou; A Kotanidou; M El Ali; V Christopoulou-Kokkinou; S G Zakynthinos
Journal:  Intensive Care Med       Date:  2001-11-10       Impact factor: 17.440

Review 7.  Linking the sepsis triad of inflammation, coagulation, and suppressed fibrinolysis to infants.

Authors:  Mary A Short
Journal:  Adv Neonatal Care       Date:  2004-10       Impact factor: 1.968

8.  Procoagulant protein levels are differentially increased during human endotoxemia.

Authors:  P H Reitsma; J Branger; B Van Den Blink; S Weijer; T Van Der Poll; J C M Meijers
Journal:  J Thromb Haemost       Date:  2003-05       Impact factor: 5.824

9.  D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.

Authors:  Rafael Noal Moresco; Luis Cláudio Rosa Vargas; Carlos Franco Voegeli; Roberto Christ Vianna Santos
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

10.  Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].

Authors:  Gary T Kinasewitz; S Betty Yan; Bruce Basson; Philip Comp; James A Russell; Alain Cariou; Suzane L Um; Barbara Utterback; Pierre-Francois Laterre; Jean-François Dhainaut
Journal:  Crit Care       Date:  2004-02-10       Impact factor: 9.097

View more
  5 in total

1.  The Screening of Fixation-Related Infection in Patients Undergoing Conversion Total Hip Arthroplasty after Failed Internal Fixation of Hip Fractures: A Single-Central Retrospective Study.

Authors:  Hong Xu; Li Liu; Jinwei Xie; Duan Wang; Zeyu Huang; Wenqi Wang; Zongke Zhou
Journal:  Orthop Surg       Date:  2022-05-18       Impact factor: 2.279

2.  The Dynamical Assessment of Inflammatory Biomarkers in Predicting the Outcome of Septic Patients and the Response to Antimicrobial Therapy.

Authors:  Alina Orfanu; Victoria Aramă; Cristina Popescu; Cătălin Tilişcan; Adrian Streinu-Cercel; Ştefan Sorin Aramă
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-01-31

3.  Elevated plasma D-dimer levels are associated with the poor prognosis of critically ill children.

Authors:  Guan Wang; Junhui Liu; Rui Xu; Xinjie Liu
Journal:  Front Pediatr       Date:  2022-09-23       Impact factor: 3.569

4.  Circulating Vitronectin Predicts Liver Injury and Mortality in Children With Sepsis: A Prospective Observational Study.

Authors:  Chunxia Wang; Yun Cui; Huijie Miao; Ting Sun; Ye Lu; Yucai Zhang
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

5.  Study on the Clinical Significance of ACE2 and Its Age-Related Expression.

Authors:  Jie Gu; JiangWen Yin; MengJie Zhang; JinHui Li; YeMing Wu; Jun Chen; HongJun Miao
Journal:  J Inflamm Res       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.